Cerevast Therapeutics Receives CE Mark for Clotbust ER Ultrasound Stroke Treatment Device

Cerevast Therapeutics announced Monday that it has received CE mark clearance of its SonoLysis Headframe System, the Clotbust ER, providing approval to commercialize the product in Europe. The Clotbust ER is a first-in-class ultrasound device for the treatment of ischemic stroke.
The Sacramento Bee